Protagonist Therapeutics, Inc (PTGX) Total assets 2017–2025
Protagonist Therapeutics, Inc (PTGX) total assets at each fiscal year-end, per SEC filings.
$668.2MFY2025 · since FY2017: $163.7M → $668.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $668.2M | -10.3% |
| FY2024 | $744.7M | +108.1% |
| FY2023 | $358.0M | +44.4% |
| FY2022 | $247.9M | -28.7% |
| FY2021 | $347.7M | +7.2% |
| FY2020 | $324.5M | +109.4% |
| FY2019 | $154.9M | +11.1% |
| FY2018 | $139.5M | -14.8% |
| FY2017 | $163.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTGX financial trends
PTGX RevenuePTGX Net incomePTGX Net marginPTGX Gross profitPTGX Gross marginPTGX Operating incomePTGX Operating marginPTGX Operating cash flowPTGX Free cash flowPTGX Capital expendituresPTGX Return on equityPTGX Stock buybacksPTGX Dividends paidPTGX Total liabilitiesPTGX Shareholders’ equityPTGX overview →